- Home
- PHT vs HRTX Comparison
PHT vs HRTX Comparison
Compare PHT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHT
- HRTX
- Stock Information
- Founded
- PHT 2002
- HRTX 1983
- Country
- PHT United States
- HRTX United States
- Employees
- PHT N/A
- HRTX N/A
- Industry
- PHT Investment Managers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- PHT Finance
- HRTX Health Care
- Exchange
- PHT Nasdaq
- HRTX Nasdaq
- Market Cap
- PHT 244.7M
- HRTX 206.9M
- IPO Year
- PHT N/A
- HRTX 1987
- Fundamental
- Price
- PHT $8.34
- HRTX $1.25
- Analyst Decision
- PHT
- HRTX Strong Buy
- Analyst Count
- PHT 0
- HRTX 2
- Target Price
- PHT N/A
- HRTX $4.50
- AVG Volume (30 Days)
- PHT 85.5K
- HRTX 1.4M
- Earning Date
- PHT 01-01-0001
- HRTX 11-11-2025
- Dividend Yield
- PHT 8.76%
- HRTX N/A
- EPS Growth
- PHT N/A
- HRTX N/A
- EPS
- PHT 0.98
- HRTX N/A
- Revenue
- PHT N/A
- HRTX $149,694,000.00
- Revenue This Year
- PHT N/A
- HRTX $10.62
- Revenue Next Year
- PHT N/A
- HRTX $12.99
- P/E Ratio
- PHT $7.71
- HRTX N/A
- Revenue Growth
- PHT N/A
- HRTX 9.78
- 52 Week Low
- PHT $6.41
- HRTX $1.04
- 52 Week High
- PHT $7.60
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- PHT 53.80
- HRTX 31.35
- Support Level
- PHT $8.20
- HRTX $1.25
- Resistance Level
- PHT $8.34
- HRTX $1.27
- Average True Range (ATR)
- PHT 0.04
- HRTX 0.05
- MACD
- PHT -0.45
- HRTX 0.01
- Stochastic Oscillator
- PHT 99.58
- HRTX 7.89
About PHT Pioneer High Income Fund Inc.
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.